Involvement of the histaminergic system in the nociceptin-induced pain-related behaviors in the mouse spinal cord

详细信息    查看全文

• 作者：Sakurada ; Shinobu ; Watanabe ; Hiroyuki ; Mizoguchi ; Hirokazu ; Yonezawa ; Akihiko ; Orito ; Tohru ; et. al.
• 关键词：Nociceptin ; Histamine ; GABA ; Substance P ; Nociceptive response ; Intrathecal injection
• 刊名：Pain
• 出版年：2004
• 出版时间：November, 2004
• 年：2004
• 卷：112
• 期：1-2
• 页码：171-182
• 全文大小：396 K

文摘

Intrathecal (i.t.) injection of nociceptin elicited a behavioral response mainly consisting of biting and licking, which were eliminated by the i.t. co-administration of opioid receptor-like-1 (ORL-1) receptor antagonists. The behavioral response induced by nociceptin was characteristically similar to that by i.t.-administered histamine, and was attenuated by i.t. co-administration of the H₁ receptor antagonists, but not by the H₂ receptor antagonists, whereas the H₃ receptor antagonist promoted the nociceptin-induced behavior. H₁ receptor knockout (H₁R-KO) mice did not show the nociceptin-induced nociceptive behavior, which was observed in wild-type mice. Pretreatment with a histamine antiserum or a histidine decarboxylase inhibitor resulted in a significant reduction of the response to nociceptin. The previous studies showed that NK₁ receptor antagonists and a novel substance P (SP)-specific antagonist given i.t. could reduce the behavioral response to nociceptin and histamine. On the other hand, the nociceptive response induced by nociceptin, but not histamine, was completely attenuated by the i.t. co-administration of agonists for GABA_A and GABA_B receptors. In contrast, the antagonists for GABA_A and GABA_B receptors injected i.t. showed same nociceptive response with nociceptin and histamine, and their nociceptive responses were significantly blocked by the i.t. co-administration of the H₁ receptor antagonists, but not H₂ receptor antagonists or ORL-1 receptor antagonists. The present results suggest that the activation of the ORL-1 receptor by nociceptin may induce the disinhibition of histaminergic neuron and enhance the release of histamine, which subsequently acts on the H₁ receptor located on the SP-containing neurons to produce the spinal cord-mediated nociceptive response.